Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation

Published:2019-05 Issue:5 Volume:25 Page:845-854
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Cohen Jeffrey A.^ORCID,Baldassari Laura E.^ORCID,Atkins Harold L.,Bowen James D.,Bredeson Christopher,Carpenter Paul A.,Corboy John R.,Freedman Mark S.,Griffith Linda M.,Lowsky Robert,Majhail Navneet S.^ORCID,Muraro Paolo A.^ORCID,Nash Richard A.,Pasquini Marcelo C.^ORCID,Sarantopoulos Stefanie,Savani Bipin N.^ORCID,Storek Jan,Sullivan Keith M.,Georges George E.

Funder

National Multiple Sclerosis Society

National Institute for Health Research

National Institute of Allergy and Infectious Diseases

Allergan

Biogen

Genentech

Genzyme

GlaxoSmithKline

Novartis

Roche

Sanofi

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. New insights into the burden and costs of multiple sclerosis in Europe;Kobelt;Mult Scler,2017

2. Defining the clinical course of multiple sclerosis: the 2013 revisions;Lublin;Neurology,2014

3. Natural history of multiple sclerosis: a unifying concept;Confavreux;Brain,2006

4. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process;Confavreux;Brain,2003

5. Impact of multiple sclerosis relapses on progression diminishes with time;Tremlett;Neurology,2009

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-08

2. Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates;Multiple Sclerosis and Related Disorders;2024-08

3. Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?;Current Neuropharmacology;2024-07

4. Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region;Expert Review of Pharmacoeconomics & Outcomes Research;2024-06-07

5. Sequential immunotherapy: towards cures for autoimmunity;Nature Reviews Drug Discovery;2024-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3